ArticleJournal of inflammation research2026
Identification of a Four-Biomarker Panel for the Diagnosis of Tuberculous Pleural Effusion Using Olink Proteomics.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tuberculous pleural effusion (TPE) results from an inflammatory response triggered by tuberculosis infection. If not promptly diagnosed and treated, it can lead to severe pulmonary dysfunction and the risk of infection spread. However, TPE diagnosis remains a significant challenge. This study employs Olink proteomics to explore novel methods for diagnosing TPE. Methods: In this study, we collected 20 cases each of TPE, malignant pleural effusion (MPE), and parapneumonic pleural effusion (PPE) from patients at the First Affiliated Hospital of Xinxiang Medical University in Xinxiang, China, between January and April 2024. Using Olink proteomics, we quantified 92 inflammation-related proteins in pleural effusions across these three patient groups. Differentially expressed proteins were identified, followed by enrichment and pathway analyses to explore potential underlying mechanisms. An independent validation cohort, consisting of 36 TPE samples and 29 non-tuberculous pleural effusion samples collected between April and July 2024, was used to validate the diagnostic performance of selected biomarkers by enzyme-linked immunosorbent assay (ELISA). Diagnostic accuracy was evaluated using logistic regression and receiver operating characteristic (ROC) curve analysis. Results: A total of 92 inflammation-related proteins were identified in this study. Differential analysis identified 43 proteins with distinct expression levels between TPE and MPE, and 33 between TPE and PPE. Of these, 25 proteins were uniquely expressed in TPE. ELISA validation confirmed the expression of four key inflammatory proteins: IFN-γ, CXCL9, TNF-β and PD-L1. The combined area under the curve (AUC) for these markers was 0.963, with a sensitivity of 0.944 and specificity of 1, surpassing the sensitivity and specificity of individual or other biomarker combinations. Conclusion: This study identified a diagnostic method using a combination of four biomarkers: IFN-γ, CXCL9, TNF-β, and PD-L1, which can aid in the diagnosis of TPE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.